STERIS plc (NYSE:STE) Shares Sold by Ballentine Partners LLC

Ballentine Partners LLC reduced its holdings in STERIS plc (NYSE:STE) by 5.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 879 shares of the medical equipment provider’s stock after selling 49 shares during the quarter. Ballentine Partners LLC’s holdings in STERIS were worth $213,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the business. Values First Advisors Inc. acquired a new stake in STERIS in the 3rd quarter valued at approximately $219,000. Assenagon Asset Management S.A. increased its position in STERIS by 7,418.7% in the 3rd quarter. Assenagon Asset Management S.A. now owns 309,771 shares of the medical equipment provider’s stock valued at $75,132,000 after acquiring an additional 305,651 shares during the period. Taylor Frigon Capital Management LLC increased its position in STERIS by 1.7% in the 3rd quarter. Taylor Frigon Capital Management LLC now owns 6,281 shares of the medical equipment provider’s stock valued at $1,523,000 after acquiring an additional 106 shares during the period. Riverwater Partners LLC increased its position in STERIS by 21.7% in the 3rd quarter. Riverwater Partners LLC now owns 4,847 shares of the medical equipment provider’s stock valued at $1,138,000 after acquiring an additional 864 shares during the period. Finally, Waldron Private Wealth LLC increased its position in STERIS by 102.2% in the 3rd quarter. Waldron Private Wealth LLC now owns 2,346 shares of the medical equipment provider’s stock valued at $569,000 after acquiring an additional 1,186 shares during the period. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Stock Performance

STE opened at $223.87 on Wednesday. The firm has a market cap of $22.08 billion, a PE ratio of 55.59 and a beta of 0.84. The company has a quick ratio of 1.49, a current ratio of 2.33 and a debt-to-equity ratio of 0.35. The business has a fifty day simple moving average of $234.57 and a 200-day simple moving average of $226.59. STERIS plc has a fifty-two week low of $195.47 and a fifty-two week high of $248.24.

STERIS (NYSE:STE) last issued its earnings results on Tuesday, August 6th. The medical equipment provider reported $2.14 EPS for the quarter, topping the consensus estimate of $1.98 by $0.16. The business had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.27 billion. STERIS had a return on equity of 13.85% and a net margin of 7.36%. STERIS’s revenue was down .4% compared to the same quarter last year. During the same quarter last year, the firm posted $2.00 earnings per share. As a group, equities analysts predict that STERIS plc will post 9.06 EPS for the current fiscal year.

Insider Transactions at STERIS

In other news, Director Christopher S. Holland sold 473 shares of the firm’s stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $239.68, for a total value of $113,368.64. Following the completion of the sale, the director now owns 582 shares of the company’s stock, valued at $139,493.76. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. In related news, Director Christopher S. Holland sold 473 shares of the stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $239.68, for a total transaction of $113,368.64. Following the completion of the sale, the director now directly owns 582 shares in the company, valued at approximately $139,493.76. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Michael J. Tokich sold 23,332 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $247.00, for a total value of $5,763,004.00. Following the sale, the chief financial officer now owns 42,930 shares of the company’s stock, valued at approximately $10,603,710. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research firms recently commented on STE. KeyCorp raised their target price on STERIS from $255.00 to $265.00 and gave the company an “overweight” rating in a research report on Tuesday, September 3rd. StockNews.com lowered STERIS from a “strong-buy” rating to a “buy” rating in a research note on Tuesday. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research note on Thursday, August 8th. Piper Sandler raised STERIS from a “neutral” rating to an “overweight” rating and increased their price target for the company from $230.00 to $260.00 in a research note on Thursday, October 24th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research note on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, STERIS presently has a consensus rating of “Moderate Buy” and a consensus price target of $253.00.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.